Oral silicon supplementation: an effective therapy for preventing oral aluminum absorption and retention in mammals.
Level 5 - mechanism / opinion, no new human data
Narrative review without systematic search or meta-analytic methodology
PubMed 21198634 · doi:10.1111/j.1753-4887.2010.00360.x
What was done
This narrative review synthesizes published literature examining the physiological role of silicon in mammals, focusing on its ability to limit oral aluminum absorption and systemic retention, and evaluates the proposed connection between silicon, aluminum accumulation, and Alzheimer's disease.
What was found
The abstract reports no quantitative data, effect sizes, or specific metrics. It notes qualitatively that multiple studies suggest dietary silicon supplementation can reduce oral aluminum absorption and prevent chronic aluminum accumulation in the mammalian brain. It also highlights ongoing controversy regarding whether brain aluminum accumulation is an etiological driver or a consequence of Alzheimer's disease.
Why it matters
The review outlines a potential dietary intervention to reduce heavy metal accumulation in brain tissue, which is relevant to hypotheses linking aluminum toxicity to neurodegenerative disease.
Limits
This is a narrative review without systematic search criteria or quantitative synthesis. The abstract presents no human clinical trial data, relies on animal and mechanistic models, and explicitly acknowledges that the causal link between aluminum accumulation and Alzheimer's disease pathophysiology remains unproven.
Cited by
- context Evidence shows that drinking silica water over several months chelates substances from the brain and improves condition in autism.